In March 2025, the company declared new strategies for the immediate-to-consumer providing of its Wegovy weight loss drug. The company set up a completely new pharmacy, termed NovoCare, which might cost buyers $499 per 30 days for usage of the drug, less than half the cost of the drug via other pharmaceutical distribution networks.[fifty three]The